在病原和抗凝固治疗的最新进展 败血症诱导的凝血病治疗
Chit Man1, Yuan An1, Guo-Xin Wang1
1Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
Journal of inflammation research
|January 23, 2025
概括
败血症诱导的凝血病包括免疫血栓,一种过度活跃的凝血反应,使结果恶化. 了解炎症和凝血之间的复杂相互作用,特别是内皮细胞的作用,是治疗败血症的关键.
科学领域:
- * 败血症的病理生理学
- * 免疫血栓形成和凝血障碍
- * 血液静止中的内皮细胞功能.
背景情况:
- *凝血病是败血症的常见和致命并发症.
- * 免疫血栓,虽然对感染控制至关重要,但可以导致有害的全身血栓炎症.
- * 在败血症中,炎症和凝血之间存在复杂的关系.
研究的目的:
- * 审查与败血症相关的凝血病的机制.
- * 探索内皮细胞在败血症引起的凝血病中的作用.
- *讨论抗凝剂的治疗潜力及其非抗凝剂作用.
主要方法:
- * 关于败血症,凝血病和免疫血栓形成的最近研究的文献综述.
- * 分析炎症,凝血和内皮细胞之间的相互作用.
- *讨论关于抗凝血剂在败血症治疗中的当前研究.
主要成果:
- *免疫血栓是败血症诱导的凝血病的核心,由炎症凝血失衡驱动.
- *内皮细胞显著影响免疫调节和血症中的血静.
- *抗凝剂,特别是肝素,表现出与败血症病源相关的非抗凝剂作用.
结论:
- *对败血症诱导的凝血病发病的更好理解对于临床实践至关重要.
- *对内皮细胞作用和抗凝剂机制的洞察力可以改善败血症的管理.
- *进一步的研究将有助于早期识别和有效的治疗决策的败血症患者.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
603
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
603
Extrinsic and Intrinsic Pathways of Hemostasis
5.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.1K
Coagulation
4.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.4K
Disorders of Hemostasis
693
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
693
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
Clot Retraction and Fibrinolysis
3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K


